Director Hong Jung-gi Increases Stake from 0.94% to 1.84% via Open Market Purchase, Signaling Management Confidence
Registered executive and de facto controlling shareholder Hong Jung-gi purchased 394,758 common shares of ilShinbiobase at 1,202 won per share via open market transaction on June 2, 2026
His total holdings increased from 416,675 shares (0.94%) to 811,433 shares (1.84%)
Purchase price equals current market price, indicating no premium or discount
Although a small increase (0.90%p), voluntary insider buying signals management confidence and commitment
[AI Summary]Hong Jung-gi's open market purchase represents a modest stake increase (0.90%p), but as a de facto controlling shareholder's voluntary buy, it implies confidence in the company's value. While it may serve as a positive short-term signal, it is not a direct shareholder return policy such as large-scale buybacks or dividends, so a neutral interpretation is warranted.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders